Tempus AI, Inc. Class A Common Stock (TEM) — Technical state
As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 42 out of 100 (momentum 96 · quality 20 · valuation 16), as of 2026-11-11.
- Signal: Up 11% at the close — Above both trend lines; one of the day's strongest moves. (as of 2026-11-09)
- Trend: Tempus AI, Inc. Class A Common Stock trades 17.7% above its 50-day and 47.6% above its 200-day moving average. (as of 2026-11-09)
Tempus AI is a healthcare technology company that links a clinician's desktop to laboratory diagnostics, genomic sequencing and an analytics platform holding multimodal patient data. It runs oncology-focused assays such as xT and xR, pharmacogenomic and inherited-condition tests, and licenses de-identified clinical and molecular data libraries called Insights to life-sciences researchers.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TEM overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Above both trend lines; one of the day's strongest moves.
Ranked #33 on today’s Directional Flow — Rising fastest list (scan of 2026-11-10).
The moving-average stack
- vs 20-day+18%
- vs 50-day+17.7%
- vs 200-day+47.6%
- 52-week band19.1% off the high · +107.1% off the low
- Streak2 consecutive up sessions
- 50-day crossprice crossed up through the 50-day 2 sessions ago
- Stochastic%K 65.6 · %D 59.1 · up cross
Continue: the TEM chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-09
Quick answers
What is the current Closelooknet signal on TEM?
Up 11% at the close — Above both trend lines; one of the day's strongest moves. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is TEM above its 50-day and 200-day moving averages?
As of 2026-11-09, Tempus AI, Inc. Class A Common Stock trades +17.7% above its 50-day and +47.6% above its 200-day average, with the 20-day +18% away.
How far is TEM from its 52-week high?
19.1% below the 52-week high and 107.1% above the 52-week low, as of 2026-11-09.
Mentioned on Closelooknet
Where TEM appears in the diary — 2 pieces, newest first. Every link is our own writing.
Long reads
- Agentic Application Software: The SaaSpocalypse Map
But AI agents in clinical workflows are coming: Tempus AI is building AI-native oncology tools, Intuitive Surgical is embedding AI in robotic surgery, and Veeva owns the regulatory data infrastructure for life sciences.
Dailies
- Yields reverse back through the buyback within hours — 10-year 4.692%, 30-year 5.234% — as Walmart's double beat is sold 9% and Bitcoin holds a new local high above 71,500
NDSN adds 5.71% to 327.61, within reach of its 52-week high; TEM gains 7.10% to 65.60.
Related in the Closelooknet universe
then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HQY HealthEquity Incindustry
- VEEV Veeva Systems Inc Class Aindustry
- HNGE Hinge Health, Inc.industry
- TDOC Teladoc Incindustry
- CERT Certara Incindustry
- SDGR Schrodinger Incindustry
- BTSG BrightSpring Health Services, Inc. Common Stockindustry
- PME.AX Pro Medicus Ltdindustry
- PRVA Privia Health Group Incindustry
- DOCS Doximity Incindustry
- WAY Waystar Holding Corp. Common Stockindustry
- HTFL Heartflow, Inc. Common Stockindustry
- GDRX Goodrx Holdings Incindustry
- HSTM HealthStream Incindustry
- OMCL Omnicell Incindustry
- EQS.PA Equasens S. A.industry
- CRW.L Craneware Plcindustry
- OMDA Omada Health, Inc. Common Stockindustry
- HALO Halozyme Therapeutics Incsector
- ARGX.BR Argen-Xsector